ALNYLAM PHARMACEUTICALS, INC. Quarterly Return On Equity in % from Q1 2011 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Alnylam Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2011 to Q2 2024.
  • Alnylam Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2024 was 47.9 %, a 89.9% decline year-over-year.
  • Alnylam Pharmaceuticals, Inc. annual Return On Equity for 2023 was 167 %.
  • Alnylam Pharmaceuticals, Inc. annual Return On Equity for 2022 was -1.29K %, a 1079% decline from 2021.
  • Alnylam Pharmaceuticals, Inc. annual Return On Equity for 2021 was -109 %, a 58.4% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 47.9 -428 -89.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 131 -1.25K -90.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 167 +1.45K Oct 1, 2023 Dec 31, 2023
Q3 2023 206 +636 Jul 1, 2023 Sep 30, 2023
Q2 2023 476 +680 Apr 1, 2023 Jun 30, 2023
Q1 2023 1.38K +1.52K Jan 1, 2023 Mar 31, 2023
Q4 2022 -1.29K -1.18K -1079% Oct 1, 2022 Dec 31, 2022
Q3 2022 -431 -336 -356% Jul 1, 2022 Sep 30, 2022
Q2 2022 -204 -116 -131% Apr 1, 2022 Jun 30, 2022
Q1 2022 -137 -60.5 -78.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 -109 -40.3 -58.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -94.4 -28.4 -43.1% Jul 1, 2021 Sep 30, 2021
Q2 2021 -88.4 -30 -51.4% Apr 1, 2021 Jun 30, 2021
Q1 2021 -76.9 -19.3 -33.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -68.9 -13.1 -23.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -66 -13.1 -24.7% Jul 1, 2020 Sep 30, 2020
Q2 2020 -58.4 -1.99 -3.53% Apr 1, 2020 Jun 30, 2020
Q1 2020 -57.6 -3.68 -6.82% Jan 1, 2020 Mar 31, 2020
Q4 2019 -55.8 -6.34 -12.8% Oct 1, 2019 Dec 31, 2019
Q3 2019 -52.9 -11.1 -26.4% Jul 1, 2019 Sep 30, 2019
Q2 2019 -56.4 -19.7 -53.4% Apr 1, 2019 Jun 30, 2019
Q1 2019 -54 -17.1 -46.6% Jan 1, 2019 Mar 31, 2019
Q4 2018 -49.5 -8.4 -20.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 -41.8 +5.12 +10.9% Jul 1, 2018 Sep 30, 2018
Q2 2018 -36.8 +8.77 +19.3% Apr 1, 2018 Jun 30, 2018
Q1 2018 -36.8 +6.09 +14.2% Jan 1, 2018 Mar 31, 2018
Q4 2017 -41.1 -2.24 -5.77% Oct 1, 2017 Dec 31, 2017
Q3 2017 -47 -13 -38.2% Jul 1, 2017 Sep 30, 2017
Q2 2017 -45.5 -15.9 -53.9% Apr 1, 2017 Jun 30, 2017
Q1 2017 -42.9 -16.5 -62.4% Jan 1, 2017 Mar 31, 2017
Q4 2016 -38.9 -17.7 -83.9% Oct 1, 2016 Dec 31, 2016
Q3 2016 -34 -16.9 -98.6% Jul 1, 2016 Sep 30, 2016
Q2 2016 -29.6 -13.8 -86.9% Apr 1, 2016 Jun 30, 2016
Q1 2016 -26.4 -11.4 -76.3% Jan 1, 2016 Mar 31, 2016
Q4 2015 -21.1 +17.4 +45.2% Oct 1, 2015 Dec 31, 2015
Q3 2015 -17.1 +31.3 +64.6% Jul 1, 2015 Sep 30, 2015
Q2 2015 -15.8 +42.1 +72.7% Apr 1, 2015 Jun 30, 2015
Q1 2015 -15 +57.4 +79.3% Jan 1, 2015 Mar 31, 2015
Q4 2014 -38.6 -8.51 -28.3% Oct 1, 2014 Dec 31, 2014
Q3 2014 -48.4 -3.06 -6.76% Jul 1, 2014 Sep 30, 2014
Q2 2014 -57.9 -11.2 -23.9% Apr 1, 2014 Jun 30, 2014
Q1 2014 -72.3 -21.2 -41.5% Jan 1, 2014 Mar 31, 2014
Q4 2013 -30.1 +30.8 +50.6% Oct 1, 2013 Dec 31, 2013
Q3 2013 -45.3 -11.1 -32.6% Jul 1, 2013 Sep 30, 2013
Q2 2013 -46.8 -13.9 -42.4% Apr 1, 2013 Jun 30, 2013
Q1 2013 -51.1 -14.7 -40.5% Jan 1, 2013 Mar 31, 2013
Q4 2012 -60.9 -17.2 -39.3% Oct 1, 2012 Dec 31, 2012
Q3 2012 -34.2 +1.24 +3.5% Jul 1, 2012 Sep 30, 2012
Q2 2012 -32.9 -1.79 -5.76% Apr 1, 2012 Jun 30, 2012
Q1 2012 -36.4 -6.23 -20.7% Jan 1, 2012 Mar 31, 2012
Q4 2011 -43.7 Oct 1, 2011 Dec 31, 2011
Q3 2011 -35.4 Jul 1, 2011 Sep 30, 2011
Q2 2011 -31.1 Apr 1, 2011 Jun 30, 2011
Q1 2011 -30.2 Jan 1, 2011 Mar 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.